Join us for a Behavioral Insights Student Group lunch with BIG faculty member Ameet Sarpatwari (HMS).
Ameet Sarpatwari is an Instructor in Medicine at Harvard Medical School, an Associate Epidemiologist at Brigham and Women’s Hospital, and Assistant Director of the Program On Regulation, Therapeutics, And Law (PORTAL) within the Division of Pharmacoepidemiology and Pharmacoeconomics. His research draws upon his interdisciplinary training as an epidemiologist and lawyer and focuses on the effects of laws and regulations on therapeutic development, approval, use, and related public health outcomes. Among other projects, he is currently examining the public health impact of risk evaluation and mitigation strategies, the comparative safety and effectiveness of authorized and non-authorized generics, and the effect of variation in state drug product selection laws on generic drug prescribing.
RSVP here. Lunch will be served.
Topic: Patients’ Perceptions of and Responses to Changes in Pill Appearance
Synopsis: Generic versions of a drug must have the same active ingredient, dosage form, and dosage strength in comparison to their brand-name counterpart but may vary in appearance, which may impact adherence—a multi-billion dollar public health problem. In this talk, Dr. Sarpatwari will discuss a study we performed assessing the preferences, perceptions, and response of patients who experienced a change in the appearance of a generic medication and discuss the policy implications of our findings.